Fund provides key early investments in ideas
By Barbara Berg
Because it's not always obvious when
studies of a basic biological process will lend themselves to
broader applications, researchers often use the phrase "serendipity
in science."
Hutch research often leads to discoveries
that may improve diagnosis or treatment, but many findings need
more study to demonstrate potential public benefit. The Hutch's
New Technology Development Fund provides short-term support to
bring projects to a stage in which they attract venture financing
or a licensing partner.
"A small investment at this early
stage can produce dramatically increased valuation and success
of Center technologies," says Dr. Lee Hartwell, president
and director.
Dr. David Hockenbery in the Clinical
Research Division (see related story) and Dr. Mark Roth in the
Basic Sciences Division are the first two recipients of financial
support from the fund.
The fund is made possible by Washington
Research Foundation, as well as private donors. For application
information, contact Rose Beer in Technology Transfer at rbeer@fhcrc.org or Ext.
6309. For general information about the fund, contact Pat McCowan
in Development at pmccowan@fhcrc.org
or Ext. 2673.